Regenerative Medical Technology Group Inc. Financial Ratios — RMTG

Profitability (USD)

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-9,684.26	-8,224.95	-4,791.04	-270.53	-63.35	-179.09	-166.05	-188.02
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	83.55	-36.35	-84.45	20.2	34.29	57.31	69.53	68.73	55.11
EBITDA Margin (%)	-1,712.12	-508.81	-5,282.89	-812.64	-2,255.99	-67.45	-16.81	7.35	-11.49
Operating Margin (%)	-1,712.12	-509.2	-5,285.55	-814.1	-2,265.32	-77.43	-29.68	1.98	-17
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	46.92	- -
Pretax Margin (%)	-1,289.31	-4,105.61	-8,335.2	-10,703.47	-2,939.41	-364.33	-407.21	-135.43	-153.18
Profit Margin (%)	-1,289.31	-4,105.61	-8,335.2	-10,703.47	-2,942.42	-359.87	-407.21	-135.43	-153.18
Net Income to Common Margin (%)	-1,289.31	-4,105.61	-8,335.2	-10,703.47	-2,942.42	-359.87	-407.21	-135.43	-153.18
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

Credit Ratios API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	1	2	6	14	15	18	20	20
ST Debt	- -	1	1	- -	2	7	15	18	17
LT Debt	- -	- -	- -	6	12	8	2	2	2
Total Debt/EBITDA	-0.76	-3.19	-1.01	-12.91	-1.38	-14.67	-43.57	66.45	-33.39
Net Debt/EBITDA	-0.74	-3.07	-1	-12.82	-1.08	-13.04	-42.25	61.67	-30.68
Total Debt/EBIT	-0.76	-3.19	-1.01	-12.89	-1.37	-12.78	-24.68	246.97	-22.57
Net Debt/EBIT	-0.74	-3.06	-1	-12.79	-1.07	-11.36	-23.93	229.22	-20.74
EBITDA to Interest Expense	-1.3	-0.48	-2.79	-0.11	-3.63	-0.23	-0.06	0.05	-0.08
EBITDA-CapEx/Interest Expense	-1.3	-0.49	-2.79	-0.11	-3.63	-0.28	-0.12	0.02	-0.16
EBIT to Interest Expense	-1.3	-0.48	-2.79	-0.11	-3.64	-0.27	-0.11	0.01	-0.12
Interest Expense	- -	1	1	4	3	4	6	6	7
Common Equity/Total Assets	-32,612.43	-13,108.53	-27,890.12	-2,917.12	-72.62	-148.3	-757.06	-715.9	-774.08
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	-5.78	-893.51	172.49	255.17	-58.53	-30.27	-15.87
Long-Term Debt/Total Assets (%)	- -	- -	1,259.04	2,562.69	127.28	99.79	84.24	57.88	53.67
Total Debt/Equity (%)	-14.76	-17.91	-21.85	-90.17	-201.62	-126.37	-80.99	-73.29	-56.32
Total Debt/Capital (%)	-17.31	-21.82	-27.96	-917.03	198.4	479.2	-425.98	-274.36	-128.94
Total Debt/Total Assets (%)	4,809.94	2,346.9	6,092.27	2,630.16	146.4	187.4	613.1	524.65	435.95
Net Debt to Equity	-14.45	-17.23	-21.53	-89.5	-157.54	-112.36	-78.54	-68.02	-51.76
Net Debt/Capital (%)	-16.9	-20.82	-27.44	-852.73	273.78	888.82	-366.22	-219.61	-111.46
EBITDA	-1	- -	-2	- -	-10	-1	- -	- -	-1
EBITDA-CapEx	-1	- -	-2	- -	-10	-1	-1	- -	-1
Operating Income (Loss)	-1	- -	-2	- -	-10	-1	-1	- -	-1

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	- -	0.01	- -	0.05	0.71	0.14	0.02	0.04	0.03
Current Ratio	- -	0.01	- -	0.05	0.72	0.14	0.03	0.04	0.03
Quick Ratio	- -	0.01	- -	0.05	0.71	0.14	0.02	0.04	0.03
CFO/Avg Current Liab	- -	-0.07	-0.06	-0.08	-3.85	-0.14	-0.02	0.03	-0.02
Common Equity/Total Assets	-32,612.43	-13,108.53	-27,890.12	-2,917.12	-72.62	-148.3	-757.06	-715.9	-774.08
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	-5.78	-893.51	172.49	255.17	-58.53	-30.27	-15.87
Long-Term Debt/Total Assets (%)	- -	- -	1,259.04	2,562.69	127.28	99.79	84.24	57.88	53.67
Total Debt/Equity (%)	-14.76	-17.91	-21.85	-90.17	-201.62	-126.37	-80.99	-73.29	-56.32
Total Debt/Capital (%)	-17.31	-21.82	-27.96	-917.03	198.4	479.2	-425.98	-274.36	-128.94
Total Debt/Total Assets (%)	4,809.94	2,346.9	6,092.27	2,630.16	146.4	187.4	613.1	524.65	435.95
CFO/Total Liabilities	-0.24	-5.35	-4.91	-4.87	-61.5	-5.55	-1.7	2.73	-1.8
CFO/CapEx	- -	-61.16	- -	- -	- -	-5.61	-1.09	3.95	-1.17
Altman's Z-Score	-4,752.23	-1,206.16	-1,993.9	-226.47	-32.38	-45.7	-119.61	-62.27	-53.13

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	50.75	45.66	65.38	176.43	153.58
Days Sales Outstanding	- -	- -	- -	- -	7.19	7.99	5.58	2.07	2.38
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	253.95	27.03
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	1.44	13.5
Accounts Payable Turnover	- -	0.18	0.14	0.11	1.03	3.06	2.2	2.63	5.35
Accounts Payable Turnover Days	- -	2,009.85	2,655.15	3,317.49	353.41	119.26	165.73	138.87	68.26
Cash Conversion Cycle	- -	-2,009.85	-2,655.15	-3,317.49	-346.22	-111.27	-160.14	-135.37	-52.38
Inventory to Cash Days	- -	- -	- -	- -	7.19	7.99	5.58	0.63	-11.13
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	- -	3	- -	- -	- -	1
- Cash & Cash Equivalents	- -	- -	- -	- -	3	2	1	1	1
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	1	2	6	14	15	18	20	20
Enterprise Value	1	1	2	6	14	14	17	19	19
Total Capital	-2	-4	-6	-1	7	3	-4	-7	-15
Total Debt/Capital (%)	-17.31	-21.82	-27.96	-917.03	198.4	479.2	-425.98	-274.36	-128.94
Total Debt / EV	0.44	0.79	0.92	0.95	0.98	1.1	1.03	1.04	1.02
EV/Sales	29.47	20.4	57.85	110.47	31.76	8.98	7.14	4.68	3.78
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	63.77	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	237.02	- -
EV/Cash Flow to Firm	2.28	3.6	8.35	1.57	- -	4.18	2.83	2.96	2.86
EV/Free Cash Flow to Firm	2.28	3.55	8.35	1.57	- -	3.94	2.67	2.87	2.62
Diluted Market Cap	- -	- -	- -	- -	3	- -	- -	- -	1
Diluted Enterprise Value	1	1	2	6	14	14	17	19	19
EV per Share	0.18	0.21	0.22	0.56	1.15	1.1	1.38	1.53	1.47
TTM Sales	- -	- -	- -	- -	- -	2	2	4	5
TTM EBITDA	-1	- -	-2	- -	-10	-1	- -	- -	-1
TTM Operating Income	-1	- -	-2	- -	-10	-1	-1	- -	-1
TTM Cash Flow to Firm	- -	- -	- -	4	-7	3	6	6	7
TTM Free Cash Flow to Firm	- -	- -	- -	4	-7	3	6	7	7

Multiples (USD)

Valuation Multiples API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-56.69	-0.83	-0.29	-0.93	-0.31	-0.25	-2.7	0.34	-5.96
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	237.02	- -
Enterprise Value	1	1	2	6	14	14	17	19	19
Low Price	0.1	0.01	0.01	0.01	0.03	0.02	0.01	0.01	0.02
EV/Sales	29.47	20.4	57.85	110.47	31.76	8.98	7.14	4.68	3.78
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	63.77	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-2.36	-0.3	-0.12	-0.03	-0.12	-0.17	-0.02	-0.09	-0.07
Price/Earnings High	-7.36	-0.6	-0.31	-0.13	-0.31	-0.75	-0.04	-0.17	-0.13
Price/Earnings Low	-0.92	-0.01	-0.02	-0.01	-0.03	-0.04	-0.01	-0.02	-0.03
Price/Book Value	-0.19	-0.05	-0.02	-0.05	-0.48	-0.02	- -	-0.01	-0.02
Price/Book Value Average	-0.49	-0.16	-0.06	-0.03	-0.24	-0.08	-0.01	-0.02	-0.02
Price/Book Value High	-1.53	-0.32	-0.16	-0.14	-0.63	-0.35	-0.02	-0.03	-0.03
Price/Book Value Low	-0.19	-0.01	-0.01	-0.01	-0.05	-0.02	- -	- -	-0.01
Price/Tangible Book Value	-0.19	-0.05	-0.02	-0.05	-0.25	-0.01	- -	-0.01	-0.02
Price/Tangible Book Value Average	-0.49	-0.16	-0.06	-0.03	-0.12	-0.05	-0.01	-0.02	-0.02
Price/Tangible Book Value High	-1.53	-0.32	-0.16	-0.14	-0.32	-0.23	-0.02	-0.03	-0.03
Price/Tangible Book Value Low	-0.19	-0.01	-0.01	-0.01	-0.03	-0.01	- -	- -	-0.01
Price/Sales	11.86	3.98	3.46	5.43	7.08	0.15	0.04	0.09	0.12
Price/Sales Average	30.49	12.38	10	3.03	3.51	0.62	0.08	0.12	0.11
Price/Sales High	94.85	24.48	26.17	14.25	9.18	2.72	0.17	0.23	0.19
Price/Sales Low	11.86	0.61	1.99	1.22	0.79	0.15	0.04	0.02	0.05
Price/Cash Flow	-56.69	-0.82	-0.29	-0.93	-0.31	-0.21	-0.22	0.42	-0.88
Price/Cash Flow Average	-145.76	-2.54	-0.83	-0.52	-0.16	-0.86	-0.47	0.57	-0.77
Price/Cash Flow High	-453.48	-5.01	-2.17	-2.43	-0.41	-3.73	-0.95	1.1	-1.41
Price/Cash Flow Low	-56.69	-0.13	-0.17	-0.21	-0.03	-0.21	-0.21	0.11	-0.38
Price/Free Cash Flow Average	-145.76	-2.58	-0.83	-0.52	-0.16	-1.04	-5.8	0.46	-5.2
Price/Free Cash Flow High	-453.48	-5.1	-2.17	-2.43	-0.41	-4.54	-11.85	0.88	-9.55
Price/Free Cash Flow Low	-56.69	-0.13	-0.17	-0.21	-0.03	-0.25	-2.67	0.09	-2.55
EV/Sales Average	55.81	30.48	67.65	107.68	28.01	9.46	7.19	4.72	3.76
EV/Sales High	146.8	44.97	91.92	120.73	33.97	11.59	7.27	4.83	3.85
EV/Sales Low	29.47	16.37	55.64	105.58	25.14	8.98	7.14	4.62	3.7
EV/EBITDA Average	-3.26	-5.99	-1.28	-13.25	-1.24	-14.02	-42.75	64.2	-32.72
EV/EBITDA High	-8.57	-8.84	-1.74	-14.86	-1.51	-17.18	-43.25	65.7	-33.52
EV/EBITDA Low	-1.72	-3.22	-1.05	-12.99	-1.11	-13.31	-42.49	62.89	-32.23
EV/EBIT Average	-3.26	-5.99	-1.28	-13.23	-1.24	-12.21	-24.21	238.62	-22.11
EV/EBIT High	-8.57	-8.83	-1.74	-14.83	-1.5	-14.96	-24.5	244.2	-22.65
EV/EBIT Low	-1.72	-3.21	-1.05	-12.97	-1.11	-11.59	-24.07	233.75	-21.78
Last Price	0.1	0.05	0.02	0.03	0.27	0.02	0.01	0.03	0.05
High Price	0.8	0.3	0.15	0.08	0.35	0.34	0.03	0.08	0.08
Enterprise Value Average	2	2	2	6	12	14	17	19	19
Enterprise Value High	4	2	3	7	15	18	18	20	20
Enterprise Value Low	1	1	2	6	11	14	17	19	19

Shares Outstanding	5	5	8	11	12	12	12	13	13
Diluted Weighted Avg Shares	3	4	5	9	11	12	12	13	13
Basic Weighted Avg Shares	3	4	5	9	11	12	12	13	13
Revenue per Share	0.01	0.01	0.01	0.01	0.04	0.13	0.19	0.33	0.4
EBITDA per Share	-0.14	-0.06	-0.3	-0.05	-0.86	-0.08	-0.03	0.02	-0.05
Operating Income per Share	-0.14	-0.06	-0.3	-0.05	-0.86	-0.1	-0.06	0.01	-0.07
Basic EPS, GAAP	-0.11	-0.5	-0.47	-0.63	-1.12	-0.45	-0.79	-0.44	-0.62
Basic EPS from Cont Ops	-0.11	-0.5	-0.47	-0.63	-1.12	-0.46	-0.79	-0.44	-0.62
Diluted EPS, GAAP	-0.11	-0.5	-0.47	-0.63	-1.12	-0.45	-0.79	-0.44	-0.62
Diluted EPS from Cont Ops	-0.11	-0.5	-0.47	-0.63	-1.12	-0.46	-0.79	-0.44	-0.62
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	- -	-0.06	-0.07	-0.03	-0.86	-0.09	-0.03	0.07	-0.06
Free Cash Flow per Basic Share	- -	-0.06	-0.07	-0.03	-0.86	-0.11	-0.06	0.05	-0.1
Cash & Equivalents per Share	- -	0.01	- -	- -	0.25	0.13	0.04	0.09	0.07
Book Value per Share	-0.52	-0.93	-0.92	-0.59	-0.56	-0.96	-1.74	-2.18	-2.64
Tangible Book Value per Share	-0.52	-0.93	-0.92	-0.59	-1.08	-1.46	-1.9	-2.33	-2.78

Regenerative Medical Technology Group Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)